(Q40669254)

22 September 2017

title

Development of an Ad7 cosmid system and generation of an Ad7deltaE1deltaE3HIV(MN) env/rev recombinant virus (English)

1 reference

22 September 2017

6

1 reference

22 September 2017

Marjorie Robert-Guroff

7

object named as

Robert-Guroff M

1 reference

22 September 2017

Nan X

1

1 reference

22 September 2017

Peng B

2

1 reference

22 September 2017

Hahn TW

3

1 reference

22 September 2017

Richardson E

4

1 reference

22 September 2017

Lizonova A

5

1 reference

22 September 2017

publication date

1 February 2003

1 reference

22 September 2017

1 reference

22 September 2017

volume

10

1 reference

22 September 2017

issue

4

1 reference

22 September 2017

page(s)

326-336

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301903

22 September 2017

exact match

0 references

cites work

Adenovirus vectors for human gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Adenovirus vectors as recombinant viral vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Gene therapy and viral vaccination: the interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Ex vivo adenovirus mediated gene transfection of human conjunctival epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Protective immunity to rotavirus-induced diarrhoea is passively transferred to newborn mice from naive dams vaccinated with a single dose of a recombinant adenovirus expressing rotavirus VP7sc

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Human adenovirus type 5 recombinants expressing simian immunodeficiency virus macaque strain gag antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Replication-defective recombinant adenovirus expressing the Epstein-Barr virus (EBV) envelope glycoprotein gp340/220 induces protective immunity against EBV-induced lymphomas in the cottontop tamarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Investigation of promoter function in human and animal cells infected with human recombinant adenovirus expressing rotavirus antigen VP7sc

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

The use of adenoviral vectors for gene therapy and gene transfer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Adenoviruses as gene-delivery vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: implication for gene therapy with adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Macrophage depletion increases the safety, efficacy and persistence of adenovirus-mediated gene transfer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Antibody to CD40 ligand inhibits both humoral and cellular immune responses to adenoviral vectors and facilitates repeated administration to mouse airway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Adenovirus-human immunodeficiency virus (HIV) envelope recombinant vaccines elicit high-titered HIV-neutralizing antibodies in the dog model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

High level expression of the envelope glycoproteins of the human immunodeficiency virus type I in presence of rev gene using helper-independent adenovirus type 7 recombinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Role of the type 5 adenovirus gene encoding the early region 1B 55-kDa protein in pulmonary pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Rapid construction of adenoviral vectors by lambda phage genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Cloning and sequencing of the cellular-viral junctions from the human adenovirus type 5 transformed 293 cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Recruitment of the Crm1 nuclear export factor is sufficient to induce cytoplasmic expression of incompletely spliced human immunodeficiency virus mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Immunogenicity of recombinant human adenovirus-human immunodeficiency virus vaccines in chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Production of first generation adenovirus vectors: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Use of the cosmid adenoviral vector cloning system for the in vitro construction of recombinant adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Generation of recombinant adenovirus vector with infectious adenoviral genome released from cosmid-based vector by simple procedure allowing complex manipulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Constructing adenoviral vectors by using the circular form of the adenoviral genome cloned in a cosmid and the Cre-loxP recombination system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Nuclear export of the E1B 55-kDa and E4 34-kDa adenoviral oncoproteins mediated by a rev-like signal sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

The nuclear export signal within the E4orf6 protein of adenovirus type 5 supports virus replication and cytoplasmic accumulation of viral mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Selective extraction of polyoma DNA from infected mouse cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Selective infection of human CD4+ cells by simian immunodeficiency virus: productive infection associated with envelope glycoprotein-induced fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

Update on adenovirus and its vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

7 January 2021

Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

7 January 2021

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

7 January 2021

Generation of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

7 January 2021

"Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

7 January 2021

Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

7 January 2021

Circumvention of immunity to the adenovirus major coat protein hexon.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

7 January 2021

Evaluation of adenovirus type 4 and type 7 recombinant hepatitis B vaccines in dogs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

7 January 2021

An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

7 January 2021

Factors associated with slow disease progression in macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope priming-gp120 boosting regimen and challenged vaginally with SIVmac251.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

7 January 2021

Induction of neutralizing antibodies to T-cell line-adapted and primary human immunodeficiency virus type 1 isolates with a prime-boost vaccine regimen in chimpanzees.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

7 January 2021

A conformational C4 peptide polymer vaccine coupled with live recombinant vector priming is immunogenic but does not protect against rectal SIV challenge

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

7 January 2021

Comparison of nucleotide sequences of the early E1a regions for subgroups A, B and C of human adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

7 January 2021

Comparison of the nucleotide sequences of early region E1b DNA of human adenovirus types 12, 7 and 5 (subgroups A, B and C)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301903

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301903

1 reference

Dimensions Publication ID

22 September 2017

1033527864

0 references

1 reference